ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY financial statements, including revenue, expenses, and profit
The total revenue of 2190 for the last semiannual is 451.81 M HKD, and it's 13.92% higher compared to the previous semiannual. The net income of H2 24 is 34.05 M HKD.